-transparent.png){kind=logo}
Immunoreactive dynorphin (I-dynorphin) was measured by radioimmunoassay in human cerebrospinal fluid (CSF). I-dynorphin concentration in CSF was 30 +/- 2 pg/ml. Sephadex G-25 column chromatography showed the main peak eluted at the position of dynorphin-(1-17). HPLC elution profile of this major peak from gel filtration showed a large peak corresponding to the position of dynorphin-(1-17) and small peaks corresponding to the positions of dynorphin-(1-13), dynorphin-(1-12) and other unknown peptides.
Related Publications
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
March 1987,
Regulatory peptides,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
April 1980,
The Journal of clinical endocrinology and metabolism,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
February 1980,
The Journal of clinical endocrinology and metabolism,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
December 1986,
Regulatory peptides,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
January 2007,
The Journal of neuropsychiatry and clinical neurosciences,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
April 1974,
The Journal of clinical endocrinology and metabolism,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
December 1980,
The Journal of clinical investigation,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
April 1988,
The Journal of endocrinology,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
September 1986,
Annals of neurology,
F Tozawa, and
T Suda, and
S Tachibana, and
N Tomori, and
H Demura, and
K Shizume
June 1977,
Clinical endocrinology,
